4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000020
Chief Medical Officer sold 2,170 shares at $27.38 ($59,415)
- Chief Medical Officer acquired 2,170 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-04-09 | Option exercise 10b5-1 | +2,170 | $16.00 | $34,720 | 78,310 | D |
| Rodman David Malcom Chief Medical Officer | 2026-04-09 | Sale 10b5-1 | −2,170 | $27.38 | $59,415 | 76,140 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-04-09 | Option exercise · Stock Option 10b5-1 | −2,170 | 21,706 | D | ||
| Open-market sales · 2,170 sh · avg $27.38 · $59,415 | |||||||
Loading xslF345X06/wk-form4_1776129225.xml…